RAP 0.00% 20.5¢ raptor resources limited

Ann: ResAppDx-EU in Use at COVID-19 Respiratory Clinic, page-27

Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #
ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 440 Posts.
    lightbulb Created with Sketch. 322
    I wonder how many Doctors worldwide could use this right now...

    “Our doctors have found ResAppDx-EU invaluable in helping them make differential diagnoses of respiratory disease. Being a non-contact diagnostic aid, ResAppDx-EU is especially useful when assessing patients in the difficult conditions associated with managing possible COVID-19 cases.”
 
watchlist Created with Sketch. Add RAP (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.